Compare HIO & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIO | SOPH |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.0M | 367.7M |
| IPO Year | N/A | 2021 |
| Metric | HIO | SOPH |
|---|---|---|
| Price | $3.65 | $4.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | ★ 353.0K | 86.6K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 10.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.52 | $2.59 |
| 52 Week High | $4.05 | $5.70 |
| Indicator | HIO | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 43.48 | 49.23 |
| Support Level | $3.62 | $4.55 |
| Resistance Level | $3.89 | $5.30 |
| Average True Range (ATR) | 0.04 | 0.27 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 25.00 | 43.24 |
Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.